Horák P - Search Results

1

[Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes].

Horák P, Hermanová Z, Ordeltová M, Faltýnek L, Kusá L, Budíková M, Vavrdová V, Opíchalová D, Ciferská H, Scudla V. Horák P, et al. Vnitr Lek. 2004 Jun;50(6):422-7. Vnitr Lek. 2004. PMID: 15346634 Czech.

2

The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value.

Ciferská H, Horák P, Hermanová Z, Ordeltová M, Zadrazil J, Tichý T, Scudla V. Ciferská H, et al. Among authors: horak p. Clin Rheumatol. 2007 May;26(5):723-8. doi: 10.1007/s10067-006-0389-9. Epub 2006 Nov 14. Clin Rheumatol. 2007. PMID: 17103120

3

[The importance of determination of interleukin-10 in the blood of patients with systemic lupus erythematosus].

Scudla V, Horák P, Faltýnek L, Pospísil Z, Budíková M, Hermanová Z. Scudla V, et al. Among authors: horak p. Cas Lek Cesk. 1998 Jan 26;137(2):44-7. Cas Lek Cesk. 1998. PMID: 9511265 Czech.

4

[Vascular intercellular adhesive molecule-1 (VCAM-1)--a new indicator of activity in systemic lupus erythematosus?].

Scudla V, Horák P, Faltýnek L, Pospísil Z, Budíková M, Hermanová Z. Scudla V, et al. Among authors: horak p. Vnitr Lek. 1997 May;43(5):307-11. Vnitr Lek. 1997. PMID: 9601854 Czech.

5

[The autoantibody profile and disease activity in patients with systemic lupus erythematosus].

Horák P, Hermanová Z, Faltýnek L, Pospísil Z, Scudla V. Horák P, et al. Vnitr Lek. 1997 Oct;43(10):639-44. Vnitr Lek. 1997. PMID: 9601876 Czech.

6

Clinical utility of selected disease activity markers in patients with systemic lupus erythematosus.

Horák P, Scudla V, Hermanovó Z, Pospisil Z, Faltýnek L, Budiková M, Kusá L. Horák P, et al. Clin Rheumatol. 2001;20(5):337-44. doi: 10.1007/s100670170023. Clin Rheumatol. 2001. PMID: 11642515

7

The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value.

Ciferská H, Horák P, Heřmanová Z, Ordeltová M, Zadražil J, Tichý T, Ščudla V. Ciferská H, et al. Among authors: horak p. Clin Rheumatol. 2007 May;26(5):852. doi: 10.1007/s10067-007-0571-8. Clin Rheumatol. 2007. PMID: 27520703 No abstract available.

8

C1q complement component and -antibodies reflect SLE activity and kidney involvement.

Horák P, Hermanová Z, Zadrazil J, Ciferská H, Ordeltová M, Kusá L, Zurek M, Tichý T. Horák P, et al. Clin Rheumatol. 2006 Jul;25(4):532-6. doi: 10.1007/s10067-005-0110-4. Epub 2005 Nov 26. Clin Rheumatol. 2006. PMID: 16311713

9

Expression of nucleic acid binding Toll-like receptors in control, lupus and transplanted kidneys--a preliminary pilot study.

Ciferska H, Horak P, Konttinen YT, Krejci K, Tichy T, Hermanova Z, Zadrazil J. Ciferska H, et al. Among authors: horak p. Lupus. 2008 Jun;17(6):580-5. doi: 10.1177/0961203307088130. Lupus. 2008. PMID: 18539713

10

Intima media thickness measurement as a marker of subclinical atherosclerosis in SLE patient.

Smrzova A, Horak P, Skacelova M, Hermanova Z, Langova K, Zadrazil J, Novotny D. Smrzova A, et al. Among authors: horak p. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014 Sep;158(3):404-11. doi: 10.5507/bp.2013.054. Epub 2013 Jul 29. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014. PMID: 23945845 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

503 results

Search Page

Filters